Medical specialists from Japan tagged as investigators in clinical trials studying Fibrosarcoma

Total 4 results

Atushi Manabe
Seen in:
- Hokkaido, Sapporo, Hokkaido University Hospital
Trials:
- NCT03899792 (Principal Investigator)
Conditions:
Ayumu Arakawa
Seen in:
- Tokyo, Chuo-ku, National Cancer Center Hospital
Trials:
- NCT03899792 (Principal Investigator)
Conditions:
Katsutsugu Umeda
Seen in:
- Kyoto, Kyoto University Hospital
Trials:
- NCT03899792 (Principal Investigator)
Conditions:
Shuhei Karakawa
Seen in:
- Hiroshima, Hiroshima University Hospital
Trials:
- NCT03899792 (Principal Investigator)
Conditions:

Clinical Trials on Fibrosarcoma

Bayer

Completed

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database (EPI VITRAKVI)

Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion | Infantile Fibrosarcoma

France
National Cancer Institute (NCI)

Completed

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

Recurrent Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Dermatofibrosarcoma Protuberans | Adult Fibrosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Terminated

Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma

Sarcoma

Canada, United States, Australia, New Zealand
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline

Terminated

Phase II Pazopanib Study in Advanced Dermatofibrosarcomas (DFSP-PAZO)

Dermatofibrosarcomas of DARIER FERRAND(DFSP)

France
Mayo Clinic

Completed

Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

Dermatofibrosarcoma Protuberans

United States
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Central Nervous System Neoplasm | Solid Neoplasm | Recurrent Acute Leukemia | Refractory Acute Leukemia | Infantile Fibrosarcoma

United States, Canada
Institut Claudius Regaud

Recruiting

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group (MIRAS)

Soft Tissue Sarcoma | Perivascular Epithelioid Cell Neoplasms | Epithelioid Sarcoma | Alveolar Soft Part Sarcoma | Desmoplastic Small Round Cell Tumor | Clear Cell Sarcoma | Sclerosing Epithelioid Fibrosarcoma | Low Grade Fibromyxoid Sarcoma | Malignant Solitary Fibrous Tumors | Epithelioid Hemangioendothelioma

France
Sarcoma Alliance for Research through Collaboration

Completed

Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans

Dermatofibrosarcoma Protuberans

United States
Dermatologic Cooperative Oncology Group

Completed

Imatinib in Dermatofibrosarcoma Protuberans (DFSP)

Dermatofibrosarcoma

Germany
Loxo Oncology, Inc.
Eli Lilly and Company

Recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors (LIBRETTO-121)

Soft Tissue Sarcoma | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Infantile Fibrosarcoma | Infantile Myofibromatosis

United States, Australia, Japan, Canada, Germany, Korea, Republic of, France, Spain, United Kingdom, Denmark, Italy

Medical specialists from Japan tagged as investigators in clinical trials studying Fibrosarcoma

Clinical Trials on Fibrosarcoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations